# Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

> **NCT02244164** · NA · TERMINATED · sponsor: **Erasme University Hospital** · enrollment: 5 (actual)

## Conditions studied

- Type 2 Diabetes
- Incretinomimetics
- Pancreas

## Interventions

- **DRUG:** Incretinomimetics
- **DRUG:** DPP-4 inhibitors

## Key facts

- **NCT ID:** NCT02244164
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2023-02-13
- **Final completion:** 2023-02-13
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Recruitment too slow
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02244164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02244164, "Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02244164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*